Strengthening the FDA ORA senior executive team?s leadership capability and performance
Ended Awarded Last action
- Contract number
- 75F40123F19262
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,144,015
Award facts
- Contract value 100% obligated
- $1,144,015.46 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$58,877 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,202,892 |
About this award
The Food and Drug Administration issued a BPA call to Brillient Corporation under the Professional and Technical Services Blanket Purchase Agreement, with a ceiling of $1,144,015.46 and an award date of January 25, 2023. The call supports strengthening the FDA's Office of Regulatory Affairs senior executive team's leadership capability and performance. The call is competitive 8(a) set-aside, priced on a time and materials basis, with place of performance in Silver Spring, Maryland, and completion targeted for July 11, 2026.
Through fiscal year 2024, the call has invoiced $582 thousand across 1.3 FTEs and 2,710 contractor hours, at a derived blended government-paid rate of $214.89 per hour. Year-over-year invoiced labor trended upward from $452 thousand and 2,012 hours in FY2023 to $582 thousand in FY2024. In FY2024, all contractor hours were delivered through one subcontractor.
Quick answers
Who was awarded contract 75F40123F19262?
75F40123F19262 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on January 25, 2023.
How much is contract 75F40123F19262 worth?
The government has obligated $1,144,015 on 75F40123F19262.
Is contract 75F40123F19262 an order under another contract?
Yes. 75F40123F19262 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40123F19262 competed?
The extent of competition for 75F40123F19262 was full and open competition. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award